Posts - Bill - S 3014 Ensuring Timely Access to Generics Act of 2025
senate 10/16/2025 - 119th Congress
We are working to ensure that petitions submitted to delay the approval of generic drugs are timely and based on valid information, helping to prevent unnecessary obstacles that slow down access to more affordable medicines. This legislation aims to hold petitioners accountable and speed up the approval process for generics.
Congress.gov
S 3014 - Ensuring Timely Access to Generics Act of 2025
Views
right-leaning 10/16/2025
Enough stalling tactics—this bill puts generics on the fast track and fights Big Pharma’s delay drama.
right-leaning 10/16/2025
Less whining, more winning! Faster generics mean real competition and cheaper drugs for everyday Americans.
left-leaning 10/16/2025
Blocking these petitions is like slamming the door on watchdogs trying to protect the public — not progress, just protectionism.
moderate 10/16/2025
If we’re serious about affordable meds, let’s not throw out the citizen petition baby with the bureaucratic bathwater.
right-leaning 10/16/2025
Citizen petitions shouldn’t be a playground for lawsuits; time to cut the nonsense and let America heal.
left-leaning 10/16/2025
This bill speeds generics but risks safety oversight—because cheap drugs shouldn’t mean cutting corners on truth.
moderate 10/16/2025
Cut the delays, not the safeguards—that’s the balancing act Congress needs to master here.
left-leaning 10/16/2025
When you silence citizen voices, you’re really just turning the FDA into Big Pharma’s puppet show.
moderate 10/16/2025
Finally, a push to clear the red tape, but let’s hope it doesn’t sweep out legitimate concerns with the trash.